← Funding radar

Apmonia Therapeutics

Latest funding round: 11 M$

Apmonia Therapeutics develops anticancer peptide therapies targeting the tumour microenvironment. Its candidates aim to treat solid tumours in cancer patients.

Visit apmonia-therapeutics.com ↗

There are no linked jobs yet.

View all jobs